Makeup use linked to testosterone levels? Not so fast, says retraction

Psych SciA psychology journal is retracting a 2015 paper that attracted press coverage by suggesting women’s hormone levels drive their desire to be attractive, after a colleague alerted the last author to flaws in the statistical analysis.

The paper, published online in November, found women prefer to wear makeup when there is more testosterone present in their saliva. The findings were picked up by various media including Psychology Today (“Feeling hormonal? Slap on the makeup”), and even made it onto reddit.com.

However, upon discovering a problem in the analysis of the data, the authors realized that central finding didn’t hold up, according to Psychological Science‘s interim editor, Stephen Lindsay: Continue reading Makeup use linked to testosterone levels? Not so fast, says retraction

2001 Fujii papers retracted — finally. What took so long?

BJO

Nearly four years after an analysis of more than 160 papers by Yoshitaka Fujii concluded the chances the data were authentic were infinitesimally small, the British Journal of Ophthalmology has decided to formally retract one of the papers included in that review.

The name Yoshitaka Fujii should ring a bell — an alarm bell, in fact — for our readers. He’s firmly listed in the number one spot on our leaderboard, with more than 180 retractions.

The recently retracted paper — “Ramosetron compared with granisetron for the prevention of vomiting following strabismus surgery in children” — has been included in that retraction total for years, because it was part of a seminal 2012 analysis by J.B. Carlisle that put the odds of data occurring naturally in some of Fujii’s papers at: Continue reading 2001 Fujii papers retracted — finally. What took so long?

Letter calls for retraction of yoga weight loss paper

IntJYoga_2016_9_1A paper concluding that a specific series of yoga poses is effective at promoting weight loss in obese women has a call for retraction in a letter to the editor of the International Journal of Yoga. 

The study followed 87 women for 8 weeks as they completed a regular routine of  yoga, circuit training, or walking on a treadmill. “Suryanamaskar: An equivalent approach towards management of physical fitness in obese females” concludes that

All three methods were effective in weight and physical fitness management.

But a group of heath researchers at the University of Alabama at Birmingham led by David Allison failed to replicate the statistical tests on some of the data. In a recent letter to the editor, “Unsubstantiated conclusions from improper statistical design and analysis of a randomized controlled trial,” they express skepticism about the paper’s claims, and ask the journal to retract it:

Continue reading Letter calls for retraction of yoga weight loss paper

Wikipedia page reincarnated as paper: Authors plagiarized paper on reincarnation

Untitled-2

When an entry on Wikipedia dies, can it come back as a paper in a peer-reviewed journal?

Apparently not, according to the Indian Journal of Psychiatry, which has retracted a 2013 article about reincarnation after discovering the authors lifted text from a “old revision” of a Wikipedia entry on the subject.

The article, “The mystery of reincarnation,” states that:

One of the mysteries puzzling human mind since the origin of mankind is the concept of “reincarnation” which literally means “to take on the flesh again.”

The article presents how different religions describe reincarnation, and apparently provides “some research evidence” about the phenomenon. But according to the retraction notice, the authors, led by AK Nagaraj of Mysore Medical College, took on the words again of other writers:

Continue reading Wikipedia page reincarnated as paper: Authors plagiarized paper on reincarnation

You’ve been dupe’d: Data so nice, you see them twice

j repro infertLast Friday we resurrected a previous feature of Retraction Watch, compiling five retractions that appeared to be simple acts of duplication.

This week, we spotlight another five unrelated retractions which, as we said last week, cover duplications in which the same – or some of the same – authors published the same – or some of the same – information in two different papers.

Most duplications are straightforward — all authors simply send the same or similar study to two or more journals, a violation of most journals’ terms of use.  For instance: Continue reading You’ve been dupe’d: Data so nice, you see them twice

Karolinska may reopen inquiry into star surgeon Macchiarini, following documentary’s revelations

dr-paolo-macchiarini
Paolo Macchiarini

Karolinska Institutet may reopen its misconduct investigation into acclaimed surgeon Paolo Macchiarini following new allegations revealed during a documentary series by Swedish Television.

According to a recent statement from KI: Continue reading Karolinska may reopen inquiry into star surgeon Macchiarini, following documentary’s revelations

Lancet retracts 24-year-old paper by “father of nutritional immunology” after reopening inquiry

lancetFollowing questions from outside experts, a retraction of a related paper, a university investigation and a court case, The Lancet has decided to retract a 1992 paper by Ranjit Kumar Chandra, the self-proclaimed “father of nutritional immunology.

In a lengthy retraction note included in the January 30 issue, the journal explains that:

the balance of probabilities in our judgment is that the reliability of the 1992 Lancet paper by Chandra can no longer be assured.

Chandra is objecting to the retraction.

This retraction was a long time coming, so sit back and relax as we fill in the backstory. Continue reading Lancet retracts 24-year-old paper by “father of nutritional immunology” after reopening inquiry

“Innocent mistake” leads to bioethics article retraction

jbiA July article that incorrectly called out nine leading bioethics journals for their lack of availability to researchers in low- and middle-income countries is being pulled after editors of the indicted journals refuted the allegations.

The last author on the article, published in the Journal of Bioethical Inquiry, told us an “innocent mistake” and difficulty navigating a website led the authors to incorrectly note that nine journals had not made their contents available through the World Health Organization’s Health InterNetwork Research Initiative database (HINARI), which gives bioethicists who live in low- and middle-income countries access to research articles either free of charge or at reduced cost. The authors argued that the mistake didn’t affect the paper’s conclusions, but the journal disagreed, and opted to pull the paper entirely.

After searching through the database, first author Subrata Chattopadhyay mistakenly determined that the journals had not made their contents available through HINARI, when in fact they were listed but on a different part of the website.

Even with the error, the authors maintain that their conclusions remain sound and that the field is shaped by a “hegemony of Western bioethics.” Continue reading “Innocent mistake” leads to bioethics article retraction

Sharing data is a good thing. But we need to consider the costs.

Liz Wager

Last week, the International Committee of Medical Journal Editors proposed requiring authors to share deidentified patient data underlying the published results of clinical trials within six months of publication. The proposal has earned much support but also some concerns – for example that other scientists might poach the findings, acting as the New England Journal of Medicine dubbed “research parasites.” Elizabeth Wager, a member of the board of directors of our parent organization, disagrees with that concern, but raises another issue – namely, the unintended consequences of data sharing on other, more effective initiatives to make reporting more transparent.

The recent proposal from the ICMJE may appear, at first glance, a positive step towards better clinical trial reporting. However, I’m concerned that this new requirement might undermine other more effective initiatives to increase the efficiency of research, such as the publication of protocols and full study reports. Here’s why.

All actions have costs, risks, and benefits: Making partial data sharing a condition of publication is no exception. The costs are hard to quantify but undoubtedly not trivial.  Putting clinical data into a usable format and making it meaningful to other researchers requires considerable time and effort by knowledgeable people. To this must be added the costs of establishing and maintaining suitable repositories and of checking compliance.

I’m not saying that open data does not have any benefits. Continue reading Sharing data is a good thing. But we need to consider the costs.

Investigation of undisclosed conflicts in catheter paper uncovers flawed data, too

cov150hAn investigation into a paper that compared infection rates from different types of central lines started with an allegation about a failure to disclose a conflict of interest, and ended up concluding that the science in the paper was flawed.

The 2013 paper — now retracted by the American Journal of Infection Control — suggested a particular kind of connector between the catheter and the patient could reduce some of the notoriously deadly bloodstream infections associated with the procedure, according to a press release that publicized the work. But last year, the journal issued an expression of concern for the paper, noting there were questions about the data. The retraction note reveals an investigation at Georgia Regents University — now known as Augusta University — started looking into undisclosed conflicts of interest in the paper, and ultimately concluded the science was flawed.

Here’s the retraction note, published in the January 1st 2016 issue of the journal, for “Comparison of central line-associated bloodstream infection rates when changing to a zero fluid displacement intravenous needleless connector in acute care settings

Continue reading Investigation of undisclosed conflicts in catheter paper uncovers flawed data, too